| 1 |
35189245 | Silibinin exerts anti-cancer activity on human ovarian cancer cells by increasing apoptosis and inhibiting epithelial-mesenchymal transition (EMT). | 2022 May 20 |
1 |
| 2 |
32748663 | Cancer Chemopreventive Activities of Silibinin on Colorectal Cancer through Regulation of E-Cadherin/β-Catenin Pathway. | 2021 |
1 |
| 3 |
31612353 | Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion. | 2020 Jan |
1 |
| 4 |
28926892 | [Effect and mechanism of silibinin on the inhibition of ALK positive NSCLC cells by sensitizing crizotinib]. | 2017 Sep 23 |
1 |
| 5 |
27753543 | STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer. | 2016 Dec 16 |
1 |
| 6 |
23764119 | Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model. | 2013 Nov |
1 |
| 7 |
24012496 | Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness. | 2013 Dec |
1 |
| 8 |
20428808 | Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors. | 2010 Jun |
1 |
| 9 |
19578386 | Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression. | 2009 Aug |
3 |